24/7 Market News Snapshot 25 September, 2025 – PLUS THERAPEUTICS, Inc. Common Stock (NASDAQ:PSTV)

DENVER, Colo., 25 September, 2025 (www.247marketnews.com) – (NASDAQ:PSTV) are discussed in this article.
PLUS THERAPEUTICS, Inc. (PSTV) is experiencing a notable pre-market surge, with shares currently trading at $0.487, reflecting a 20.48% increase from the previous close of $0.404. This rise in trading volume to 9.01 million shares indicates a growing investor confidence in the company’s innovative approaches within the biotech sector. Such trends suggest potential opportunities for investors as the market continues to respond favorably to PLUS THERAPEUTICS’ advancements.

In a significant development, CNSide Diagnostics, LLC, a wholly-owned subsidiary of PLUS THERAPEUTICS, has announced a national partnership with UnitedHealthcare Insurance Company, effective September 15, 2025. This agreement is pivotal as it enhances access to the CNSide® Cerebrospinal Fluid Tumor Cell Enumeration laboratory developed test (LDT), impacting over 51 million lives throughout the United States.

The CNSide® CSF Assay Platform is poised to improve the diagnosis and treatment of patients with leptomeningeal metastases—a serious complication linked to various cancers. Backed by nine peer-reviewed studies, this test has demonstrated high clinical efficacy, boasting a sensitivity rate of 92% and specificity of 95%. Since its rollout in 2020, more than 11,000 tests have been conducted across 120 cancer institutions, influencing treatment strategies in 90% of cases.

Exclusively offered through CNSide Diagnostics, the CNSide® CSF Assay allows for early detection and detailed analysis of tumor cells and circulating tumor DNA in cerebrospinal fluid, thereby enhancing patient management outcomes.

Through strategic partnerships and forward-thinking diagnostic solutions, PLUS THERAPEUTICS is firmly committed to improving care for patients with complex malignancies, ultimately reshaping the healthcare landscape and offering hope to those affected by challenging forms of cancer.

Related news for (PSTV)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.